ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 710969 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 710969; 2) Community: the network communities that were significantly associated with the response to NSC 710969; 3) Molecule: the relationships between components within communities and NSC 710969; 4) MDR: the compounds that were significantly associated with the NSC 710969.

NSC Compound Enrichment Correlation
NSC 706992 Null 0.035202825328704 -0.066600409
NSC 715407 Null 0.0352028253287042 0.1860529
NSC 716503 Null 0.0352028253287042 0.079213922
NSC 718781 Erlotinib hydrochloride 0.0352028253287042 -0.079017554
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0352028253287042 0.31994969
NSC 720134 Null 0.0352028253287042 -0.12359297
NSC 726217 Combretastatin A4-analogue 0.0352028253287042 0.20464919
NSC 731704 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. 0.0352028253287042 0.2227194
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.0352028253287042 0.23541137
NSC 734287 6-(3-Aminopropyl)-5,6-dihydro-7,8,9-trimethoxy-3-nitro-5,11- dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0352028253287042 0.14222775
Total:168  Current:127    [First] [Prev] [Next] [Last]